Clinical Trial Update: Does Induction PEG-Intron in Combination With Rebetol Enhance the Sustained Response Rates in Patients With CHC [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating induction with PEG-Intron plus Rebetol to potentially improve sustained virologic response in patients with chronic hep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PegIntron (pegylated interferon alfa-2b)
• Rebetol (ribavirin)

Snippet

Sponsor: Brooke Army Medical Center | Conditions: Hepatitis C | Phase 4 | Status: COMPLETED